While the global efforts to develop a safe and affordable coronavirus vaccine are going on in full swing, a big question remains unanswered: how and when India, one of the world’s most populous countries and is only behind the United States and Brazil in infections numbers, will be able to make it available to the public.Since the government is yet to announce a national policy on COVID-19 immunisation, public health experts believe that Ayushman Bharat, the central government’s flagship health insurance scheme, to be the way forward to undertake the vaccination programme for the poor with possible price control on the vaccine for people outside the government’s universal healthcare programme.However, this massive and potentially multi-year immunisation programme, which is expected to start with the elderly and the other vulnerable segments, including frontline workers, needs to have a proven vaccine before addressing the other uncertainties like timelines and availability.Close In India, Hyderabad-based Bharat Biotech and Pune-based Serum Institute have initiated human trials on their respective vaccine candidates, which are among close to 170 vaccines currently under various stages of clinical development globally. related news PM Modi wants India’s frontline corona warriors to be first to get COVID-19 vaccine Wield the magic wand… Read full this story
- ‘Just beautiful’: Another COVID-19 vaccine, from newcomer Moderna, succeeds in large-scale trial
- Govt to deploy ECI staff to deliver 600 million COVID-19 vaccine jabs, use standard cold storage
- 100 people per session, electoral rolls, mobile sites: Centre’s Covid-19 vaccine guidelines
- Oxford Covid-19 vaccine may become first to get DCGI's nod for emergency use
- Bharat Biotech’s COVID-19 vaccine: Phase 1 trials find no serious adverse events
- Oxford Covid-19 vaccine may become the first to get Indian regulator’s nod for emergency use
- Covid-19 vaccine will be ‘voluntary’
- WHO: Equitable, Global Distribution of 2 Billion COVID-19 Vaccine Doses to Begin in 2021
- COVID-19 vaccine: Zee News exclusive on phase-wise inoculation, infrastructure for vaccination and more
- Covid-19 vaccine: India’s key role in ending the pandemic | Analysis
India’s COVID-19 vaccine puzzle: Bharat Biotech, Serum set to start human trials; but big questions remain unanswered have 326 words, post on www.moneycontrol.com at July 12, 2020. This is cached page on Gatofuns. If you want remove this page, please contact us.